Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02049905
Title Phase 3 Study to Treat Patients With Soft Tissue Sarcomas
Recruitment Completed
Gender both
Phase Phase III
Variant Requirements No
Sponsors CytRx
Indications

sarcoma

Therapies

Dacarbazine

Doxorubicin

Ifosfamide

Pazopanib

Aldoxorubicin

Docetaxel + Gemcitabine

Age Groups: adult | child
Covered Countries USA | CAN


No variant requirements are available.